INOVIQ Exosome Diagnostic Solutions

Breast cancer monitoring study | Study 2 design Study 2: To determine the accuracy of SubB2M/CA15-3 to identify breast cancer recurrence For personal use only pre-treatment post-treatment time 3 time 4 time 5 no recurrent disease (n=12) SubB2M/CA15-3 test comparison between recurrence and non- recurrence recurrent disease (n=12) IVD CA15-3 test comparison between test INOVIQ 12 12

View entire presentation